NCT04357639View on ClinicalTrials.gov

Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP )

CompletedOBSERVATIONAL
Enrollment

1,040

Participants

Timeline

Start Date

May 28, 2020

Primary Completion Date

January 31, 2021

Study Completion Date

July 31, 2021

Conditions
HIV Patients
Interventions
OTHER

No intervention

No intervention: Usual care for nasopharyngeal sampling and blood sampling for COVID-19 detection

Trial Locations (6)

75004

Hopital universitaire de Hotel Dieu, Paris

75015

Hopital Universitaire de Necker, Paris

77000

Centre hospitalier de Melun (GHSIF), Melun

94000

CHI Créteil, Créteil

94010

CHU Henri Mondor, Créteil

94190

CHI Villeneuve St Georges, Villeneuve-Saint-Georges

All Listed Sponsors
collaborator

Centre Hospitalier Intercommunal Villeneuve St Georges

UNKNOWN

lead

Centre Hospitalier Intercommunal Creteil

OTHER

NCT04357639 - Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP ) | Biotech Hunter | Biotech Hunter